The Effect of Virtual Reality Application on Pain, Fear and Anxiety in Patients Undergoing Colonoscopy

NCT06003543 | Completed

• 1 other identifier: E-19003918-730.08.03-347141
• Study Type: interventional
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

Colonoscopy; It is a method that allows viewing the large intestines and diagnosing or treating gastrointestinal system diseases by entering through the anus with a flexible, thin tube with a camera at the end, called a colonoscope. All parts of the large intestine with colonoscopy; ascending colon, hepatic flexure, transverse colon, splenic flexure, descending colon, sigmoid colon, rectum and anal canal by retroflexion can be evaluated. Colonoscopic interventions applied in gastroenterology cause pain, fear and anxiety in patients.

Conditions

Virtual Reality

Keywords

Fear; Colonoscopy,; Pain; Anxiety

Outcome Measures

Primary Outcomes (4)

• Visual Analog Scale -Pain

  Patients are asked to show the intensity of pain on a 10 cm long vertical or horizontal line during activity or rest. It has numbered shapes ranging from 1-10. The line has 0 at the beginning and 10 at the end. 10 means unbearable pain, 0 means no pain. The VAS scale is frequently used in the evaluation of pain severity. While the patient marks the pain he/she has felt on this line, each point marked is measured in cm

  1 hours later

• Visual Analog Scale - Fear

  Patients are asked to show the intensity of fear on a 10 cm long vertical or horizontal line during activity or rest. It has numbered shapes ranging from 1-10. The line has 0 at the beginning and 10 at the end. 10 means unbearable fear, 0 means no fear. The VAS scale is frequently used in the evaluation of fear severity. While the patient marks the fear he/she has felt on this line, each marked point is measured in cm

  1 hours later

• Visual Analog Scale -Anxiety

  Patients are asked to show the intensity of anxiety on a 10 cm long horizontal line during activity or rest. The line has 0 at the beginning and 10 at the end. 10 means unbearable pain, 0 means no pain. VAS is frequently used in the evaluation of pain intensity. While the patient marks the anxiety he/she has felt on this line, each marked point is measured in cm

  1 hours later

• State-Trait Anxiety Inventory

  Developed by Spielberg et al. (1970) to measure the state and trait anxiety levels of individuals, the scale, which consists of two parts and the English name is Speilberg's State-Trait Anxiety Inventory (STAI), is a self-tested reliability and validity study in Turkish by Öner and Le Compte (1977). assessment scale (37-38) In this study, the part of the scale measuring trait anxiety was used to determine the trait anxiety levels of the patients. Trait Anxiety Inventory is a 4-point Likert-type with 20 items and is scored as "never": 1, "a little": 2, "a lot": 3, "completely": 4, according to the severity of the feelings, thoughts or behaviors expressed by the items. . There are direct or reverse scored statements in the scale.

  1 hours later

Study Arms (2)

Virtual Reality

EXPERIMENTAL

virtual glasses will be applied

Behavioral: Virtual Reality

Control

NO INTERVENTION

no application will be made

Interventions

Virtual Reality BEHAVIORAL

Virtual Reality

Virtual Reality

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Able to speak and understand Turkish
• Having cognitive competence to answer data collection tools
• Absence of communication problems (hearing, language, understanding, etc.)
• Not having a psychiatric diagnosis
• Absence of a history of convulsions
• Patients who underwent local application in colonoscopy

You may not qualify if:

• Those with communication problems
• Those with psychiatric problems

Sponsors & Collaborators

• Ataturk University: lead

Study Sites (1)

Fırat university

Elâzığ, Center, 25240, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain; Anxiety Disorders

Condition Hierarchy (Ancestors)

Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Mental Disorders

Study Officials

• Gülcan B.TURAN

  Firat University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: August 16, 2023
• First Posted: August 22, 2023
• Study Start: October 15, 2023
• Primary Completion: January 1, 2024
• Study Completion: March 1, 2024
• Last Updated: March 10, 2025

Record last verified: 2025-03

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)